Keyword: Teva

News

Opioid Makers Angling to Settle out of Court

03.09.2019 - After Johnson & Johnson last week was ordered to pay $572 million to the state of Oklahoma, analysts and other observers said the verdict could prompt other opioid makers to think...

News

J&J Told to Pay $572 Million in Opioid Case

28.08.2019 - A US district judge in Norman, Oklahoma, has ordered Johnson & Johnson to pay $572 million for allegedly fueling the crisis sweeping the country. The country’s largest healthcare...

News

Teva Faces Israeli Back-tax Claim

22.01.2019 - Israel’s tax authority is seeking to recover $271 million in retroactive tax for 2014-2015 from drugmaker Teva, reports said. The newspaper Calcalist said Teva, one of the country...

News

DCAT Announces New Board of Directors

02.11.2018 - Paolo Magri, senior vice president, business development at Advitech, has been elected president of the Drug, Chemical & Associated Technologies Association (DCAT). Also elected to...

News

FDA Approves Teva’s Generic EpiPen

23.08.2018 - After two years of trying, Israeli generics producer Teva Pharmaceutical Industries has finally gained approval by the US Food and Drug Administration (FDA) for its copy of Mylan’s...

News

Warren Buffett Invests in Teva

20.02.2018 - Berkshire Hathaway, the investment vehicle of US billionaire Warren Buffett, has acquired 18.9 million American Depositary Receipts (ADRs) of embattled Israeli generics maker Teva...

News

Loss-making Teva Progresses Turnaround

12.02.2018 - Troubled Israeli generics giant Teva Pharmaceuticals is making "strong progress" on its turnaround plan, despite an even higher loss – approaching $12 billion – in the 2017 fourth...

News

Teva Takes Back a few Job Cuts

03.01.2018 - After two weeks of protest in Israel, generics giant Teva has temporarily taken back about a third of the planned job cuts at its plant in Jerusalem. Original plans called for 340...